Interdisciplinary E-health Based Follow-up of Preterm Born Children (NeoUp)

June 3, 2026 updated by: PD Dr. Annette Conzelmann, University Hospital Tuebingen

Interdisciplinary, E-health Based, Multimodal Follow-up of Somatic, Sleep-related and Psychological Symptoms of Very Immature Preterm Born Babies in Different Age Groups for the Further Development of Previous Care Structures

The aim of the study is to assess mental and somatic symptoms of preterm born children at the ages of 2, 5 and 10 by a multidisciplinary team and to evaluate an app that screens for these symptoms. Furthermore, there will be an evaluation of an intervention by our multidisciplinary team that provides recommendations for further treatment and diagnostic procedures of the children.

Study Overview

Status

Active, not recruiting

Conditions

Detailed Description

  • At first, there will be focus groups with experts and affected families to finalize and optimize the study procedure. After that, 90 children will be recruited (ages 2, 5 and 10)
  • T0: App-questions for the children at the ages of 5 and 10 and the parents of all children to mental, somatic and sleep problems of the children and well-being of the parents, sleep tracking and recording of a sleep sequence of the children; differentiated examinations and questionnaires to mental and somatic problems of the children by interdisciplinary study team
  • Interdisciplinary study team meeting to generate recommendations for the families
  • Interdisciplinary study team recommendations for the families
  • T1: Comparable to T0 but only measurements that were assessed with questionnaires/at home plus post-experimental questionnaire
  • Focus groups with participating families and the study team experts for evaluation of the study procedure and intervention

Study Type

Interventional

Enrollment (Estimated)

90

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Tübingen, Germany, 72076
        • University Hospital Tuebingen

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • female and male preterm born children (<32 week of pregnancy) that are treated at the clinic in Tübingen and their parents
  • Existence of systematical neonatal data and consent of the care person to use this data
  • Existence of the data of the 2 year regular follow-up (for the 5 and 10 year olds)

Exclusion Criteria:

  • lack of access to a mobile phone/tablet including internet access
  • insufficient knowledge of the German language of both parents

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Diagnostic assessments and intervention
All families get a diagnostics and intervention recommendations.
All families get the same diagnostics and receive individual treatment recommendations.
Other Names:
  • Differentiated diagnostics and treatment recommendations

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Bayley Scales of Infant and Toddler Development
Time Frame: Baseline
IQ testing
Baseline
Wechsler Intelligence Scale for Children (WISC-V)
Time Frame: Baseline
IQ testing
Baseline
Children's Sleep Habit Questionnaire (CSHQ-DE 4-10)
Time Frame: Baseline and 36-38 weeks after baseline
Screening of sleeping behaviour
Baseline and 36-38 weeks after baseline
Sleep Self Report (SSR)
Time Frame: Baseline and 36-38 weeks after baseline
Screening of sleeping behaviour
Baseline and 36-38 weeks after baseline
Somatics
Time Frame: Baseline and 36-38 weeks after baseline
Questions to somatic symptoms (diagnoses, inpatient stays, medication, early support) physical therapy, hearing impairment or visual disturbance, pulmonary symptoms, seizure disorders, health related quality of life, body weight, size)
Baseline and 36-38 weeks after baseline
Child Behavior Checklist (CBCL)
Time Frame: Baseline and 36-38 weeks after baseline
Screening for mental illness
Baseline and 36-38 weeks after baseline
Youth Self Report (YSR)
Time Frame: Baseline and 36-38 weeks after baseline
Screening for mental illness
Baseline and 36-38 weeks after baseline
Diagnostic-system for mental illness for children and adolescents - III (DISYPS-III SCREEN FBB and SBB)
Time Frame: Baseline and 36-38 weeks after baseline
Screening for mental illness
Baseline and 36-38 weeks after baseline
KIDSCREEN-27 (The KIDSCREEN)
Time Frame: Baseline and 36-38 weeks after baseline
Health related quality of life
Baseline and 36-38 weeks after baseline
Parent's Stress Inventory (EBI)
Time Frame: Baseline and 36-38 weeks after baseline
Load as parents and relationship to the child
Baseline and 36-38 weeks after baseline
App-questions
Time Frame: Baseline and 36-38 weeks after baseline
Questions reflecting the questionnaires
Baseline and 36-38 weeks after baseline
Postexperimental questionnaire
Time Frame: 36-38 weeks after baseline
Evaluation of the study
36-38 weeks after baseline

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Demographic data
Time Frame: Baseline
age, gender, ethnicity, perinatal data from previous study participation
Baseline
Actigraphy measurement
Time Frame: Baseline
Device that the children are wearing at their wrists
Baseline
Video of a sleeping sequence
Time Frame: Baseline
The parents are taking a short video sequence of their sleeping child
Baseline
Sleep cartoon for children
Time Frame: Baseline and 36-38 weeks after baseline
Cartoon sleep behavior
Baseline and 36-38 weeks after baseline
Kiddie-Sads-Present and Lifetime Version (K-SADS PL)
Time Frame: Baseline
Screening mental Illness
Baseline
Self efficacy dealing with social situations (WIRKSOZ)
Time Frame: Baseline and 36-38 weeks after baseline
Self-efficacy measurement for social situations in children
Baseline and 36-38 weeks after baseline
Group interviews
Time Frame: Baseline and 36-38 weeks after baseline
Group interviews with experts and families to get feedback about the study procedure and needs
Baseline and 36-38 weeks after baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Annette Conzelmann, Prof. Dr., University Hospital Tuebingen
  • Principal Investigator: Axel Franz, Prof. Dr., University Hospital Tuebingen
  • Principal Investigator: Mirja Quante, Dr., University Hospital Tuebingen
  • Principal Investigator: Ándrea Bevot, Dr., University Hospital Tuebingen
  • Principal Investigator: Tobias Renner, Prof. Dr., University Hospital Tuebingen

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2023

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

December 1, 2026

Study Registration Dates

First Submitted

February 27, 2024

First Submitted That Met QC Criteria

March 26, 2024

First Posted (Actual)

April 3, 2024

Study Record Updates

Last Update Posted (Actual)

June 4, 2026

Last Update Submitted That Met QC Criteria

June 3, 2026

Last Verified

June 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

We share study material and statistical outputs.

IPD Sharing Time Frame

Any time before and after completion of the study for 10 years.

IPD Sharing Access Criteria

Upon request.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ICF
  • ANALYTIC_CODE
  • CSR

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Preterm Birth

Clinical Trials on Diagnostics and intervention recommendations

Subscribe